Phase 4 Psoriatic Arthritis Trial, Recruiting NCT07611747 Sponsor: Instituto de Investigación Marqués de Valdecilla Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Phase 4 Psoriatic Arthritis Trial, Recruiting

NCT07611747
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 50 years old or older and are willing to sign a consent form agreeing to take part
  • You have been diagnosed with at least one of the following conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, or Systemic Lupus Erythematosus, confirmed using standard medical classification guidelines
  • Your doctor has assessed your risk of developing heart disease as "low to moderate" based on a recognised scoring system (confirm with trial site)

Who may not be able to join:

  • You have previously had a heart attack, stroke, or other cardiovascular event, or you have type 2 diabetes, a hereditary cholesterol condition, or kidney disease that puts you in a "high" or "very high" heart risk category
  • You have already had an ultrasound scan of the arteries in your neck (carotid ultrasound) that led to you receiving a specific treatment as a result — whether as part of a research study or as part of your regular medical care
  • You have a medical reason why you cannot take cholesterol-lowering medications, such as a recent history of heavy alcohol use, an active liver condition, or persistently high liver enzyme levels in your blood (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Instituto de Investigación Marqués de Valdecilla
Registry
ClinicalTrials.gov
Start date
22 April 2026
Est. completion
22 April 2031

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Incidence of Major Adverse Cardiovascular Events (MACE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov